BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24268318)

  • 1. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
    Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
    Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
    Hermanova I; Zaliova M; Trka J; Starkova J
    Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
    Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
    J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
    Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.
    Rousseau J; Gagné V; Labuda M; Beaubois C; Sinnett D; Laverdière C; Moghrabi A; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Krajinovic M
    Blood; 2011 Nov; 118(22):5883-90. PubMed ID: 21972289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Asparagine synthetase activity in pediatric acute lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):272-4. PubMed ID: 16923354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
    Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
    Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
    Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
    Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.
    Akagi T; Yin D; Kawamata N; Bartram CR; Hofmann WK; Song JH; Miller CW; den Boer ML; Koeffler HP
    Leuk Res; 2009 Jul; 33(7):991-6. PubMed ID: 19054556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
    Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
    Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
    Chatzidakis K; Goulas A; Athanassiadou-Piperopoulou F; Fidani L; Koliouskas D; Mirtsou V
    Pediatr Blood Cancer; 2006 Aug; 47(2):147-51. PubMed ID: 16123993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
    Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
    Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia.
    Youssef YH; Makkeyah SM; Soliman AF; Meky NH
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):313-321. PubMed ID: 33959786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
    J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of
    Watanabe A; Miyake K; Yamada Y; Sunamura EI; Yotani T; Kagami K; Kasai S; Tamai M; Harama D; Akahane K; Goi K; Sakaguchi K; Goto H; Kitahara S; Inukai T
    Epigenetics; 2023 Dec; 18(1):2268814. PubMed ID: 37839090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
    Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
    Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.